<bill session="110" type="s" number="1056" updated="2013-07-19T22:29:23-04:00">
  <state datetime="2007-03-29">REFERRED</state>
  <status>
    <introduced datetime="2007-03-29"/>
  </status>
  <introduced datetime="2007-03-29"/>
  <titles>
    <title as="introduced" type="short">National Cancer Act of 2007</title>
    <title as="introduced" type="official">A bill to provide for a comprehensive Federal effort relating to early detection of, treatments for, and the prevention of cancer, and for other purposes.</title>
  </titles>
  <sponsor id="300043"/>
  <cosponsors>
    <cosponsor id="300013" joined="2007-03-29"/>
  </cosponsors>
  <actions>
    <action datetime="2007-03-29">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S4188"/>
    </action>
    <action state="REFERRED" datetime="2007-03-29">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Biomedical engineering"/>
    <term name="Cancer"/>
    <term name="Case management"/>
    <term name="Chemotherapy"/>
    <term name="Clinical trials"/>
    <term name="Colon cancer"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Continuum of care"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug abuse"/>
    <term name="Drug approvals"/>
    <term name="Economics and public finance"/>
    <term name="Education"/>
    <term name="Environmental health"/>
    <term name="Environmental protection"/>
    <term name="Families"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to child health services"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal aid to research"/>
    <term name="Genetic research"/>
    <term name="Government operations and politics"/>
    <term name="Governmental investigations"/>
    <term name="Health planning"/>
    <term name="Higher education"/>
    <term name="Imaging systems in medicine"/>
    <term name="Intellectual property"/>
    <term name="Lung cancer"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical screening"/>
    <term name="Medical supplies"/>
    <term name="Medical technology"/>
    <term name="Medicare"/>
    <term name="Minorities"/>
    <term name="Minority health"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Nursing"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Preventive medicine"/>
    <term name="Quality of care"/>
    <term name="Quality of life"/>
    <term name="Research centers"/>
    <term name="Scholarships"/>
    <term name="Science, technology, communications"/>
    <term name="Smoking"/>
    <term name="Social welfare"/>
    <term name="Strategic planning"/>
    <term name="Student loan funds"/>
    <term name="Tissue banks"/>
  </subjects>
  <amendments/>
  <summary>3/29/2007--Introduced.
National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research. Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening.Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention drugs that: (1) allow the Secretary to designate such drugs; and (2) provide market exclusivity for seven years for approved drugs or licensed biological products. Defines "chemoprevention drug" as a drug designed to treat a high-risk medical condition that: (1) has been diagnosed in individuals who have not been diagnosed with cancer or who do not currently have progressive, life-threatening cancer; and (2) unless treated, could develop into progressive and life-threatening cancer. Establishes the ChemoPrevention Products Board to develop chemoprevention drugs and devices.Requires the Secretary to establish a program to expand access to investigational treatments for individuals diagnosed with cancer.Amends title XVIII (Medicare) of the Social Security Act to provide coverage for cancer care coordinators who provide overall coordination and management of the medical, nursing, and other health services provided to individuals diagnosed with cancer.Allows a biorepository to adopt specified guidelines for the collection of biospecimens. Requires the Medicare Payment Assessment Commission (MedPAC) to report to Congress on developing a payment system for collecting and storing cancer tissue for research.</summary>
</bill>
